MedTrace Logo

Active Screening of Latent TB Infection, Treatment and Long Term Follow-up in Prison

NCT00767975 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 2384

Last updated 2010-11-29

No results posted yet for this study

Summary

LTBI Treatment is effective in prison

Conditions

Interventions

DRUG

isoniazid , randomized, open label

isoniazid 300mg/tab 1 tab qd, 6 months (the other treatment arm is rifampin)

DRUG

rifampin, randomized, open label

rifampin 300mg/capsule 2 caps qd, 4 months (the other treatment arm is isoniazid)

Sponsors & Collaborators

  • National Taiwan University Hospital

    lead OTHER

Principal Investigators

  • Li-Min Huang, MD, PHD · National University Hospital, Singapore

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2010-11-30
Completion
2010-11-30

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00767975 on ClinicalTrials.gov